Spire Healthcare has rejected an offer from its largest shareholder Mediclinic valuing the company at around £1.2bn. Spire said it had received a preliminary and conditional proposal from Mediclinic comprising 150 pence in cash and 0.232 new Mediclinic shares per Spire share, representing a total value of 298.6 pence per share. However, its Board (excluding…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
